SCHEMBL24258296

SCHEMBL24258296

CC1(CN)CCC(F)(F)CC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 2/20 0.33
▸ SLC6A3 Q01959 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL418177 0.85 — —
Hydrochloric Acid SCHEMBL591333 0.82 — —
SCHEMBL16119813 0.74 KDM4E (0.33) —
SCHEMBL14690311 0.74 — —
SCHEMBL3249011 0.73 — —
SCHEMBL590791 0.73 — —
SCHEMBL23602016 0.73 — —
Hydrochloric Acid SCHEMBL23175143 0.72 MEN1 (0.37) —
SCHEMBL18308 0.72 EPHX1 (0.42) —
SCHEMBL12350814 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 — — EP disclosed
Send feedback